Pharmaceutical Law Insight
Report warns of critical time for pharma patents
A looming patent cliff facing major pharmaceutical companies is pushing the industry into a critical phase in terms of drug
innovation and consolidation, according to the latest annual life sciences research from IP law firm Marks & Clerk.